BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 6369069)

  • 1. [Medullary carcinoma of the thyroid gland. Clinico-pathologic and immunohistochemical study].
    Elsner B; De Marco L; López S; Curutchet HP
    Medicina (B Aires); 1983; 43(3):263-70. PubMed ID: 6369069
    [No Abstract]   [Full Text] [Related]  

  • 2. Carcinoembryonic antigen and calcitonin as markers of malignancy in medullary thyroid carcinoma.
    Cox CE; VanVickle J; Froome LC; Mendelsohn G; Baylin SB; Wells SA
    Surg Forum; 1979; 30():120-1. PubMed ID: 395674
    [No Abstract]   [Full Text] [Related]  

  • 3. Occurrence of calcitonin, somatostatin-like immunoreactivity, and carcinoembryonic antigen in two sisters suffering from familial thyroid medullary carcinoma.
    Bethge N; Ahuja S; Diel F
    Exp Clin Endocrinol; 1986 Dec; 88(3):365-72. PubMed ID: 2881797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An immunohistochemical study in thyroid cancer.
    Beltrami CA; Barbatelli G; Criante P; Paliaga A; Amadi CE
    Appl Pathol; 1987; 5(4):229-45. PubMed ID: 2446641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Demonstration of calcitonin and carcinoembryonic antigen (CEA) in medullary carcinoma of the thyroid (MCT) by immunoperoxidase technique.
    Talerman A; Lindeman J; Kievit-Tyson PA; Dröge-Droppert C
    Histopathology; 1979 Nov; 3(6):503-10. PubMed ID: 389771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship of tissue carcinoembryonic antigen and calcitonin to tumor virulence in medullary thyroid carcinoma. An immunohistochemical study in early, localized, and virulent disseminated stages of disease.
    Mendelsohn G; Wells SA; Baylin SB
    Cancer; 1984 Aug; 54(4):657-62. PubMed ID: 6378353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medullary differentiation of anaplastic thyroid carcinoma.
    Nieuwenhuijzen Kruseman AC; Bosman FT; van Bergen Henegouw JC; Cramer-Knijnenburg G; Brutel de la Riviere G
    Am J Clin Pathol; 1982 May; 77(5):541-7. PubMed ID: 6177234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunohistochemical and serological demonstration of thyreoglobulin tissue polypeptide antigen, carcinoembryonic antigen and calcitonin in diversely differentiated thyroid gland carcinomas and thyroid gland adenomas].
    Vogel J; Oehr P; Grouls V
    Pathologe; 1985 May; 6(3):133-40. PubMed ID: 3892526
    [No Abstract]   [Full Text] [Related]  

  • 9. Mixed medullary-follicular carcinoma of the thyroid gland: a clinicopathologic variant of medullary thyroid carcinoma.
    Mizukami Y; Nonomura A; Michigishi T; Noguchi M; Ishizaki T
    Mod Pathol; 1996 Jun; 9(6):631-5. PubMed ID: 8782199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discordance between plasma calcitonin and tumor-cell mass in medullary thyroid carcinoma.
    Trump DL; Mendelsohn G; Baylin SB
    N Engl J Med; 1979 Aug; 301(5):253-5. PubMed ID: 449992
    [No Abstract]   [Full Text] [Related]  

  • 11. Mucosubstances in medullary carcinoma of the thyroid.
    Martin-Lacave I; Gonzalez-Campora R; Moreno Fernandez A; Sachez Gallego F; Montero C; Galera-Davidson H
    Histopathology; 1988 Jul; 13(1):55-66. PubMed ID: 3209191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Tumor markers in medullary thyroid carcinoma. Biochemical and immunohistochemical study].
    López-Guzmán A; Navarro E; Aramendi T
    An Med Interna; 1996 Jul; 13(7):358-9. PubMed ID: 8962990
    [No Abstract]   [Full Text] [Related]  

  • 13. Plasma and tumor levels of somatostatin (SRIF) and somatostatin immunochemistry in medullary thyroid carcinoma: apparently discrepant preliminary results.
    Franc B; Chayvialle JA; Modigliani E; Calmettes C; Caillou B; Dutrieux-Berger N; Houdent C; Kujas M
    Henry Ford Hosp Med J; 1987; 35(2-3):147-8. PubMed ID: 2891647
    [No Abstract]   [Full Text] [Related]  

  • 14. [Carcinoma of the thyroid gland with biphasic clinical course and evolution into medullary carcinoma, follicular variant. A case report and immunocytochemical demonstration of the simultaneous presence of calcitonin and thyroglobulin in neoplastic cells].
    Carlei F; Famulari A; Muzi P; Sciaratta F; Mariani P; Lomanto D; D'Alessandro M
    Minerva Chir; 1992 Apr; 47(8):773-5. PubMed ID: 1603426
    [No Abstract]   [Full Text] [Related]  

  • 15. Mixed medullary and follicular carcinoma of the thyroid.
    Pfaltz M; Hedinger CE; Mühlethaler JP
    Virchows Arch A Pathol Anat Histopathol; 1983; 400(1):53-9. PubMed ID: 6407193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The significance of immunochemically staining calcitonin and CEA in fine-needle aspiration biopsy materials from medullary carcinoma of the thyroid.
    Takeichi N; Ito H; Okamoto H; Matsuyama T; Tahara E; Dohi K
    Jpn J Surg; 1989 Nov; 19(6):674-8. PubMed ID: 2607690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medullary carcinoma of thyroid--a clinico-pathologic report of six cases.
    Wig JD; Banerjee AK; Bose SM; Katariya RN; Talwar BL
    Indian J Pathol Microbiol; 1980 Jan; 23(1):17-20. PubMed ID: 7216324
    [No Abstract]   [Full Text] [Related]  

  • 18. [Calcitonin levels in tissue culture of thyroid medullary carcinoma].
    Martin RC; Ezabella MC; Toledo SP
    Rev Hosp Clin Fac Med Sao Paulo; 1985; 40(5):220-2. PubMed ID: 3836475
    [No Abstract]   [Full Text] [Related]  

  • 19. Thyroid antibodies.
    Sobrinho-Simões M; Nesland JM; Johannessen JV
    Am J Surg Pathol; 1987 Oct; 11(10):821-4. PubMed ID: 3661825
    [No Abstract]   [Full Text] [Related]  

  • 20. [Immunohistochemical detection of calcitonin, ACTH, beta-MSH, beta-endorphin and somatostatin in medullary carcinoma of the thyroid. Immunoperoxidase study (PAP, ABC) of 10 cases].
    Charpin C; Argemi B; Cannoni M; Oliver C; Gillioz P; Vagneur JP; Toga M
    Ann Pathol; 1984; 4(1):27-35. PubMed ID: 6142718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.